Multi-Layer Insight into Neurodegenerative Diseases: Big Data and AI Perspectives

The study of neurodegenerative diseases has thus given artificial intelligence an opportunity to solve traditional problems within the context of the big data era. Most neurodegenerative disorders are associated with complex genetic fingerprints that are currently the center of intense contemporary study. Multiomic data, when combined with neuroimaging and electronic health record data, might become important in making the most detailed patient profile workable. Deep learning will make it feasible to generate intractable profiles for early pathologic diagnosis, better treatment personalization, and valuable insights into neurodegenerative diseases for drug development and repurposing. In this sense, this paper delves into how relevant research has sought to demonstrate with the available data sources in biomedicine that deep learning may play a pivotal role in getting a more precise understanding of the mechanisms behind neurodegenerative diseases such as Alzheimer’s and Parkinson’s. Diseases that are associated with a neurodegenerative course, like Alzheimer’s, Parkinson’s, and amyotrophic lateral sclerosis (ALS), create complex challenges because of their multifactorial etiologies and heterogeneous pathologies. The birth of big data and artificial intelligence (AI) has inexorably shifted the landscape of research on neurodegenerative disorders through innovative insights and opportunities for the understanding of these conditions. This abstract investigates the multi-layered approach to neurodegenerative diseases facilitated by big data and AI. AI uses vast datasets from genomics, proteomics, neuroimaging, and clinical records to develop machine learning and deep learning skills to recognize patterns and relationships, predict disease progression, and find new biomarkers and therapeutic targets. Major findings include considerably improved diagnostic accuracy, personalized therapeutic approaches, and identification of disease mechanisms that are now known to be driven by artificial intelligence analyses.

Authors

Institutions

Publication Details

Published
2024-11-23
DOI
https://doi.org/10.1109/icicat62666.2024.10922869
Citations
1
Primary Topic
Health, Environment, Cognitive Aging
Type
article
Field-Weighted Citation Impact
0.31
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Multi-Layer Insight into Neurodegenerative Diseases: Big Data and AI Perspectives

Mohammed Al‐Farouni, Zahraa Hashim Kareem, Amjad Hashem, R.K.Falih et al.
1 citations
Health, Environment, Cognitive Aging
0.31
article

Multi-Layer Insight into Neurodegenerative Diseases: Big Data and AI Perspectives

Mohammed Al‐Farouni, Zahraa Hashim Kareem, Amjad Hashem, R.K.Falih, Bijan Morteza Shoushtarian, Haqqi Ismail Jassim, Hassan Safi
article en
1 citations

Abstract

The study of neurodegenerative diseases has thus given artificial intelligence an opportunity to solve traditional problems within the context of the big data era. Most neurodegenerative disorders are associated with complex genetic fingerprints that are currently the center of intense contemporary study. Multiomic data, when combined with neuroimaging and electronic health record data, might become important in making the most detailed patient profile workable. Deep learning will make it feasible to generate intractable profiles for early pathologic diagnosis, better treatment personalization, and valuable insights into neurodegenerative diseases for drug development and repurposing. In this sense, this paper delves into how relevant research has sought to demonstrate with the available data sources in biomedicine that deep learning may play a pivotal role in getting a more precise understanding of the mechanisms behind neurodegenerative diseases such as Alzheimer’s and Parkinson’s. Diseases that are associated with a neurodegenerative course, like Alzheimer’s, Parkinson’s, and amyotrophic lateral sclerosis (ALS), create complex challenges because of their multifactorial etiologies and heterogeneous pathologies. The birth of big data and artificial intelligence (AI) has inexorably shifted the landscape of research on neurodegenerative disorders through innovative insights and opportunities for the understanding of these conditions. This abstract investigates the multi-layered approach to neurodegenerative diseases facilitated by big data and AI. AI uses vast datasets from genomics, proteomics, neuroimaging, and clinical records to develop machine learning and deep learning skills to recognize patterns and relationships, predict disease progression, and find new biomarkers and therapeutic targets. Major findings include considerably improved diagnostic accuracy, personalized therapeutic approaches, and identification of disease mechanisms that are now known to be driven by artificial intelligence analyses.

Iraqi University (IQ), University of Wasit (IQ), Al-Farahidi University, Al-Kunooze University College, University of Kut (IQ)
Openalex Percentile: Top 34%
Health, Environment, Cognitive Aging
0.31
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.